MA26392A1 - Respirateur aerosol - Google Patents

Respirateur aerosol

Info

Publication number
MA26392A1
MA26392A1 MA26712A MA26712A MA26392A1 MA 26392 A1 MA26392 A1 MA 26392A1 MA 26712 A MA26712 A MA 26712A MA 26712 A MA26712 A MA 26712A MA 26392 A1 MA26392 A1 MA 26392A1
Authority
MA
Morocco
Prior art keywords
hfa
actuator
hydrofluoroalkane
heptafluoropropane
tetrafluoroethane
Prior art date
Application number
MA26712A
Other languages
English (en)
Inventor
Gaetano Brambilla
Isabella Penza
Alessandra Ferraris
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11443627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26392(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA26392A1 publication Critical patent/MA26392A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
MA26712A 2000-01-07 2002-06-25 Respirateur aerosol MA26392A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000010A IT1317720B1 (it) 2000-01-07 2000-01-07 Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.

Publications (1)

Publication Number Publication Date
MA26392A1 true MA26392A1 (fr) 2004-12-01

Family

ID=11443627

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26712A MA26392A1 (fr) 2000-01-07 2002-06-25 Respirateur aerosol

Country Status (23)

Country Link
US (1) US20050034720A1 (fr)
EP (1) EP1244487B1 (fr)
AT (1) ATE342081T1 (fr)
AU (1) AU2512801A (fr)
BR (1) BR0107730B1 (fr)
CA (1) CA2396273C (fr)
CZ (1) CZ303394B6 (fr)
DE (1) DE60123746T2 (fr)
DK (1) DK1244487T3 (fr)
DZ (1) DZ3243A1 (fr)
EG (1) EG22790A (fr)
ES (1) ES2273800T3 (fr)
HU (1) HU229516B1 (fr)
IT (1) IT1317720B1 (fr)
JO (1) JO2506B1 (fr)
MA (1) MA26392A1 (fr)
PL (1) PL198683B1 (fr)
PT (1) PT1244487E (fr)
SA (1) SA01210645B1 (fr)
SI (1) SI1244487T1 (fr)
SK (1) SK286139B6 (fr)
TN (1) TNSN01003A1 (fr)
WO (1) WO2001049350A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
EP1450885B1 (fr) * 2001-09-28 2015-04-22 Kurve Technology, Inc. Nebuliseur nasal
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
WO2003099359A1 (fr) 2002-05-09 2003-12-04 Kurve Technology, Inc. Chambre de dispersion de particules pour nebuliseur nasal
US20070095342A1 (en) * 2005-10-18 2007-05-03 Bijan Olfati Accessorized inhaler
CA2698137A1 (fr) 2006-08-30 2008-03-06 Kurve Technology, Inc. Dispositif de generation et de delivrance d'aerosol
BRPI0603695A (pt) * 2006-09-13 2008-04-29 Cesar Eduardo Marques Da Silva aerocámara para aplicação de medicamentos aerossol com válvula geométrica
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
EP2080507A1 (fr) 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulations pharmaceutiques comprenant un médicament anticholinérgique
PL2727582T3 (pl) 2009-10-02 2016-06-30 Chiesi Farm Spa Farmaceutyczne formulacje aerozolowe formoterolu i dipropionianu beklometazonu
WO2011084316A2 (fr) * 2009-12-16 2011-07-14 3M Innovative Properties Company Formulations et procédés pour le réglage de l'administration de particules d'une certaine taille dans un aérosol-doseur
CN102695496B (zh) 2009-12-23 2014-10-01 奇斯药制品公司 用于copd的气雾剂制剂
CA2785317C (fr) 2009-12-23 2018-02-27 Chiesi Farmaceutici S.P.A. Preparation aerosol pour copd (bronchopneumopathie chronique obstructive)
EP2515853B1 (fr) 2009-12-23 2014-03-19 Chiesi Farmaceutici S.p.A. Polythérapie pour la COPD
AU2010334859A1 (en) 2009-12-23 2012-07-12 Chiesi Farmaceutici S.P.A. Combination therapy for COPD
WO2013114373A1 (fr) 2012-02-01 2013-08-08 Protalix Ltd. Formulations liquides inhalables d'adnase i
EP3384898A1 (fr) 2013-12-30 2018-10-10 Chiesi Farmaceutici S.p.A. Composition de solution d'aérosol sous pression stable de combinaison de bromure de glycopyrronium et de formotérol
US10098837B2 (en) 2016-07-28 2018-10-16 Chiesi Farmaceutici S.P.A. Combination therapy for COPD

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3622053A (en) * 1969-12-10 1971-11-23 Schering Corp Aerosol inhaler with flip-up nozzle
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4499108A (en) * 1983-06-08 1985-02-12 Schering Corporation Stable pleasant-tasting albuterol sulfate pharmaceutical formulations
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
US4584320A (en) * 1985-01-03 1986-04-22 David Rubin Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IT1244441B (it) 1990-09-13 1994-07-15 Chiesi Farma Spa Dispositivo per l'inalazione boccale di farmaci aerosol
US6006745A (en) * 1990-12-21 1999-12-28 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
CA2107792C (fr) * 1991-05-21 1997-03-25 Akwete L. Adjei Embout respiratoire pour aerosol
PL169046B1 (pl) * 1991-08-29 1996-05-31 Christoph Klein Przyrzad medyczny do inhalacji aerozolem PL PL PL PL PL
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
SE9203743D0 (sv) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5899201A (en) * 1993-05-26 1999-05-04 Minnesota Mining And Manufacturing Company Aerosol actuator
GB9311892D0 (en) * 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
PT735884E (pt) * 1993-12-20 2000-09-29 Minnesota Mining & Mfg Formulacoes de aerossol de flunisolida
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
TR199701168T1 (xx) * 1995-04-14 1998-05-21 Glaxo Wellcome Inc. Flutikazon Propionat i�in �l��lm�� doz inhaleri.
PL180880B1 (pl) * 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
CZ296209B6 (cs) * 1995-04-14 2006-02-15 Glaxo Wellcome Inc. Inhalátor a inhalacní systém
ATE373613T1 (de) * 1995-04-14 2007-10-15 Smithkline Beecham Corp Verfahren zur herstellung eines dosierinhalators
AU3811897A (en) 1996-07-24 1998-02-10 Oglios Therapeutics, Inc. Antisense oligonucleotides as antibacterial agents
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
JP2001511160A (ja) * 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6193954B1 (en) * 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
BR7702049U (pt) * 1997-09-05 1999-09-14 Chiesi Farma Spa Bico pulverizador para utilização em inalador oral para medicamentos aerossóis
NZ504021A (en) * 1997-10-17 2003-04-29 Systemic Pulmonary Delivery Lt Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6045784A (en) * 1998-05-07 2000-04-04 The Procter & Gamble Company Aerosol package compositions containing fluorinated hydrocarbon propellants
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
JP2000112547A (ja) * 1998-10-05 2000-04-21 Mitsubishi Electric Corp 基板電圧発生回路および半導体集積回路装置
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
HU226164B1 (en) * 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) * 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
AU7026800A (en) * 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
SI1273292T1 (en) * 2001-07-02 2004-12-31 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
US6616193B2 (en) * 2001-10-03 2003-09-09 Kool, L.L.C. Ventilating system connector assembly and method of use
EP1415647A1 (fr) * 2002-10-23 2004-05-06 CHIESI FARMACEUTICI S.p.A. Beta-2-agonistes à activité de longue durée dans une formulation ultrafine
SI1480615T1 (sl) * 2002-03-01 2010-07-30 Chiesi Farma Spa Superfina formulacija formoterola
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique

Also Published As

Publication number Publication date
ES2273800T3 (es) 2007-05-16
HUP0300405A3 (en) 2003-07-28
EP1244487A1 (fr) 2002-10-02
SA01210645B1 (ar) 2007-07-31
BR0107730B1 (pt) 2009-05-05
EP1244487B1 (fr) 2006-10-11
DK1244487T3 (da) 2007-02-19
SK286139B6 (sk) 2008-04-07
PT1244487E (pt) 2007-01-31
PL356849A1 (en) 2004-07-12
EG22790A (en) 2003-08-31
DE60123746T2 (de) 2007-10-11
ATE342081T1 (de) 2006-11-15
ITMI20000010A0 (it) 2000-01-07
ITMI20000010A1 (it) 2001-07-07
SI1244487T1 (sl) 2007-04-30
TNSN01003A1 (fr) 2003-04-03
CA2396273A1 (fr) 2001-07-12
PL198683B1 (pl) 2008-07-31
AU2512801A (en) 2001-07-16
JO2506B1 (en) 2009-10-05
BR0107730A (pt) 2003-02-25
DZ3243A1 (fr) 2001-07-12
IT1317720B1 (it) 2003-07-15
SK9482002A3 (en) 2002-10-08
US20050034720A1 (en) 2005-02-17
CA2396273C (fr) 2009-11-17
DE60123746D1 (de) 2006-11-23
CZ20022331A3 (cs) 2002-11-13
HUP0300405A2 (hu) 2003-06-28
WO2001049350A1 (fr) 2001-07-12
HU229516B1 (en) 2014-01-28
CZ303394B6 (cs) 2012-08-29

Similar Documents

Publication Publication Date Title
MA26392A1 (fr) Respirateur aerosol
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
ME00333B (me) Farmaceutski aerosolni preparat
IT1303788B1 (it) Formulazioni di aerosol medicinali.
DE69205177D1 (de) Pharmazeutische Aerosolformulierung.
NO20010391L (no) Medisinske aerosolformuleringer
ME00220B (me) Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
CA2445516A1 (fr) Distributeur-doseur destine a des agents liquides et en poudre
NO20030133D0 (no) Ny aerosolformulering inneholdende et polart fluorert molekyl
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases